Objective: To assess the incidence of pertussis (whooping cough) in subjects aged 50years and older in France.
Methods: Participating family physicians (FPs) using the patient record management software AxiSanté included patients aged 50years and older, who had signed an informed consent form, presenting with persistent cough for 7 to 21days. Bordetella genetic material was detected by polymerase chain reaction (PCR) on nasopharyngeal samples collected at the FP's discretion.
Results: A total of 42 FPs included 129 patients from June 2013 to August 2014 (large cities: 38; medium-sized cities: 57; rural areas: 34); 106 samples were analyzed. Overall, 30 pertussis cases were diagnosed: 10 cases confirmed by PCR, 18 purely clinical cases, and two direct epidemiological cases. The crude incidence rate per 100,000 patients aged≥50years was 103.6 (95% CI: 69.9-47.9): 77.1 in large cities, 103.1 in medium-sized cities, and 143.9 in rural areas. The extrapolated incidence rate per 100,000 persons aged≥50years was 187.1 (95% CI: 126.2-67.1): 131.1 in large cities, 256.1 in medium-sized cities, and 242.2 in rural areas.
Conclusion: The population aged 50years and older can serve as a reservoir. Its role in Bordetella pertussis circulation should be taken into account for pertussis booster vaccination programs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medmal.2017.09.002 | DOI Listing |
Zhonghua Xue Ye Xue Za Zhi
November 2024
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
This study aimed to assess the infection status of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in healthy populations in China over the past decade and analyze the differences in CMV and EBV infection and related risk factors in healthy populations before and after the lifting of coronavirus disease 2019 (COVID-19) pandemic control measures. This study retrospectively analyzes the CMV and EBV infection status of 8 827 healthy donors who underwent prehematopoietic stem cell transplantation screening at Peking University People's Hospital from January 2014 to December 2023. Logistic regression analysis was conducted to determine the risk factors for CMV and EBV infection.
View Article and Find Full Text PDFArch Phys Med Rehabil
December 2024
Gillette Children's - Department of Research, Saint Paul, MN; Department of Orthopedic Surgery, University of Minnesota - Twin Cities, Minneapolis, MN. Electronic address:
Objective: To quantify physical and psychosocial impacts of falls by age and Gross Motor Classification System (GMFCS) level in ambulatory individuals with cerebral palsy (CP).
Design: Cross-sectional survey.
Setting: Tertiary specialty hospital and online CP communities.
Sex Health
December 2024
Peking University, Institute of Population Research, Beijing, China.
Background Most population-based sexual health research in China excludes older adults. To fill the gap, this study aims to characterise sexual dissatisfaction among people aged 50years or older from a nationwide, population-representative sample and to explore its association with physical, mental, and self-reported overall health indicators. Methods Data were collected as part of the China Family Panel Studies in 2020, led by the Institute of Social Science Survey of Peking University.
View Article and Find Full Text PDFJ Infect Dis
December 2024
Servicio de Atención Primaria Camp de Tarragona. Institut Català de la Salut, 43007 Tarragona, Spain.
Background: Information concerning sex differences in pneumococcal vaccine effectiveness in adults is scarce. The main aim of this study is to compare the differences in clinical effectiveness of pneumococcal vaccination between male and female adults.
Methods: Population-based cohort study involving 1,108,634 women and 951,011 men aged ≥50years in Catalonia, Spain.
Aust J Prim Health
November 2024
Immunisation Coalition, Melbourne, Vic 3004, Australia.
Background Vaccination is important for adults to reduce the morbidity and mortality associated with infectious diseases. In Australia, many vaccines are recommended and funded under the Australian National Immunisation Program. However, a number of vaccines are recommended for adults but not funded.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!